Richardson Financial Services’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-240
Closed -$36.7K 632
2026
Q1
$36.7K Sell
240
-182
-43% -$27.9K 0.02% 340
2025
Q4
$58.2K Sell
422
-185
-30% -$24.2K 0.02% 282
2025
Q3
$77.8K Buy
607
+160
+36% +$19.5K 0.05% 238
2025
Q2
$55K Buy
447
+128
+40% +$14.4K 0.04% 246
2025
Q1
$35.6K Buy
319
+5
+2% +$532 0.03% 270
2024
Q4
$30.6K Buy
314
+31
+11% +$3.31K 0.02% 298
2024
Q3
$30.1K Hold
283
0.02% 306
2024
Q2
$30.1K Buy
+283
New +$28.4K 0.02% 293
2024
Q1
Sell
-257
Closed -$25.9K 637
2023
Q4
$25.9K Buy
+257
New +$24.8K 0.02% 261

Other funds holding NVS

Richardson Financial Services's NVS Position: Q2 2026 in Review

Richardson Financial Services sold out of Novartis (NVS) in Q2 2026, closing a stake of 240 shares — an estimated $36.7K sold.

Richardson Financial Services first reported a position in NVS in Q4 2023 and held it in 9 quarters. The position peaked at $77.8K in Q3 2025. 1,269 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Richardson Financial Services reported no remaining Novartis position as of Q2 2026 after selling out during the quarter.
  • Richardson Financial Services sold 240 Novartis shares in Q2 2026, an estimated $36.7K.
  • Richardson Financial Services first reported a position in Novartis in Q4 2023 and held it in 9 quarters.
  • Richardson Financial Services's Novartis position peaked at $77.8K in Q3 2025.
  • 1,269 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Richardson Financial Services's 13F filing for Q2 2026, filed 10 Aug 2026.